Kidswell Bio Corporation (TYO:4584)
Japan
· Delayed Price · Currency is JPY 251.00
-28.00 (-10.04%)
Jul 1, 2025, 3:30 PM JST
Kidswell Bio Revenue
In the fiscal year ending March 31, 2025, Kidswell Bio had annual revenue of 5.08B JPY with 223.90% growth. Kidswell Bio had revenue of 2.05B in the quarter ending March 31, 2025, with 4,349.86% growth.
Revenue
5.08B
Revenue Growth
+225.35%
P/S Ratio
2.17
Revenue / Employee
133.74M
Employees
38
Market Cap
11.01B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |